Evaluating the Efficacy and Safety of Roflumilast in Patients with NASH
NCT06677788
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
55
Enrollment
OTHER
Sponsor class
Conditions
Non-Alcoholic Steatohepatitis (NASH)
Interventions
DRUG:
Roflumilast 500 Mcg Oral Tablet
DRUG:
Vitamin E capsule
Sponsor
Tanta University